Tag: Market Access Strategy

  • EU HTA Joint Clinical Assessments: 7 Critical Pharma Mistakes

    EU HTA Joint Clinical Assessments: 7 Critical Pharma Mistakes

    —

    by

    wlcus_admin
    in

    EU HTA Joint Clinical Assessments (JCA): The 7 Critical Mistakes Pharma Companies Must Avoid Before Their First Submission The European healthcare landscape is undergoing one of the most significant transformations in decades. With the implementation of the European Union Health Technology Assessment (EU HTA) Regulation and the introduction of Joint Clinical Assessments (JCA), pharmaceutical and…